Golden
Johnson & Johnson Innovation

Johnson & Johnson Innovation

Johnson & Johnson Innovation is a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation for global healthcare businesses.

Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson.



In June 2013, Johnson & Johnson Innovation announced the opening of the Johnson & Johnson California Innovation Center, one of four regional hubs being established. A part of Johnson & Johnson Innovation, the goal of the California Innovation Center is to advance healthcare by catalyzing collaborations in science and technology between regional innovators and the Johnson & Johnson Family of Companies.



In March 2015, Johnson & Johnson Innovation LLC announced the opening of JLABS in South San Francisco. The Johnson & Johnson Innovation, JLABS site can accommodate up to 50 startups from across the healthcare spectrum including biotech, pharmaceutical, medical device, consumer and digital health.



JLABS provides tools and resources to help life science startups. Residents have access to infrastructure as well as year-round commercialization curriculum and networking events, onsite team for operations and business services. JLABS links regional entrepreneurs with the full breadth of Johnson & Johnson Innovation, including opportunities to discuss funding, access third-party services, attend educational events and meet with R&D experts from medical device technology, consumer healthcare product and Janssen pharmaceutical teams.



In June 2018, Johnson & Johnson Innovation's outpost of its startup incubator, JLabs, opened in Manhattan . In addition to NYC, there are JLabs in San Diego, San Francisco, Toronto, Houston, Boston and Belgium as well as another planned in Shanghai. The incubators provide J&J, one of the largest pharmaceutical companies in the world, with a view of what's happening at the startup level. Though J&J doesn't take an immediate stake in the companies, it does end up investing in some in the long-run.

Timeline

Funded Companies

12 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Grail is a biotechnology company headquartered in Menlo Park, California that was founded by Jeffrey Huber, Sjuul van den Eertweg in 2016 focused on making a medical device that can detect early stage cancer.

Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.

BiomX is a biotechnology company developing phage therapies for eradicating bacteria associated with chronic diseases.

Vor BioPharma is a biotechnology company developing hematopoietic stem cell therapy treatments for cancer.

Also known as Carbon, Carbon 3D is a company developing 3D manufacturing technology.

American technology company founded on june 11, 2014 and based in redwood city, california

A clinical cancer genomics company using liquid biopsy in cancer patients

Pulmocide is a London-based company.

E-Scape Bio is a South San Francisco, California-based company.

Provention Bio is an Oldwick, New Jersey-based company.

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

3T



South San Francisco



4D Molecular Therapeutics







6 Biotech







Ab Initio



South San Francisco



Abcombi Biosciences







Abilita Bio







Achelosis



South San Francisco



Acorn Biolabs







Actavalon







Actus Biotechnologies







Adhesys







Adicet Bio



South San Francisco



References